Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Could Invokana have been the cause of my lower-limb amputation?

September 15, 2017 By Law Offices of Thomas J. Lamb, P.A.

The FDA is investigating a connection between diabetes drugs belonging to the Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors class of drugs and the following side effects: Diabetic Ketoacidosis (DKA) Ketoacidosis Ketosis Acute Kidney Injury Kidney Failure / Renal Failure Kidney Damage Pyelonephritis (kidney infection) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, amputation risk factors, blood infection, diabetes drugs, diabetic ketoacidosis, DKA, drug injury lawsuits, Farxiga, Foot Amputation, Glyxambi, Invokamet, Invokana, Jardiance, Ketoacidosis, Ketosis, Kidney Damage, Kidney Failure, kidney infection, Leg Amputation, Pyelonephritis, Qtern, Renal Failure, sglt2 inhibitors, side effects of diabetes drugs, Sodium-Glucose Co-Transporter-2 inhibitors, Synjardy, Toes Amputation, Urinary Tract Infection, Urosepsis, UTI, Xigduo

Federal Court Invokana MDL In New Jersey With Judge Brian Martinotti

March 17, 2017 By Law Offices of Thomas J. Lamb, P.A.

Invokana (canagliflozin) was approved by the FDA in 2013.  Invokamet (canagliflozin and metformin) was approved by the FDA in 2014.  Both of these drugs were approved for use by patients with Type 2 diabetes. In December 2015 the FDA issued this Drug Safety Communication: “FDA revises labels of SGLT2 inhibitors for diabetes to include warnings … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, diabetes drugs, Diabetic Ketoacidosis (DKA), Invokamet, Invokana, Ketoacidosis, Kidney Damage, type 2 diabetes drugs

December 2016: FDA Requires Safety Warnings Label Change For Jardiance

December 20, 2016 By Law Offices of Thomas J. Lamb, P.A.

After the December 2, 2016 decision by the FDA decision by U.S. regulators to expand the health benefits for the relatively new diabetes medicine Jardiance (empagliflozin) to include preventing fatal heart attacks and strokes in type 2 diabetes patients, we saw news reports about its expected effect on Jardiance sales in the U.S. From this … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, drug injury, drug side effects, FDA, Jardiance, Ketoacidosis, Kidney Damage, Kidney Failure, mesothelioma

Farxiga / Jardiance / Invokana: Label Change Adds Ketoacidosis Warning

August 31, 2016 By Law Offices of Thomas J. Lamb, P.A.

In August 2016 the FDA sent letters to Janssen Pharmaceuticals and AstraZeneca Pharmaceuticals for label changes about fatal cases of ketoacidosis cases involving Invokana (canagliflozin), Invokamet (canagliflozin and metformin), Farxiga (dapagliflozin), and Xigduo XR (dapagliflozin and metformin extended-release). As for the other diabetes … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, Cerebral Vascular Accident (CVA), Deep Vein Thrombosis (DVT), Farxiga, Glyxambi, Heart Attacks, Invokamet, Invokana, Ischemic Stroke, Jardiance, Ketoacidosis, Kidney Damage, Kidney Failure, Myocardial Infarctions (MI), Pulmonary Embolism (PE), Pyelonephritis, Renal Failure, Synjardy, Urinary Tract Infection (UTI), Urosepsis, Xigduo

Viagra, Nexium, And Invokana: Drug Injury Lawsuits Report: Summer 2016

August 9, 2016 By Law Offices of Thomas J. Lamb, P.A.

We are currently investigating possible drug injury lawsuits against the responsible pharmaceutical companies for patients who used the drugs listed below and developed certain side effects. (1) Erectile Dysfunction (ED) Pills, Benign Prostatic Hyperplasia (BPH) Medicines, and Pulmonary Arterial Hypertension (PAH) Medications in the … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Interstitial Nephritis, Acute Kidney Injury, Adcirca, Cialis, Farxiga, Glyxambi, Invokamet, Invokana, Jardiance, Ketoacidosis, Kidney Disease, Levitra, Melanoma, Revatio, Staxyn, Stendra, Synjardy, Viagra, Xigduo

Invokana / Farxiga / Jardiance: UTIs Then Urosepsis And Pyelonephritis

August 2, 2016 By Law Offices of Thomas J. Lamb, P.A.

To date, most attention has been directed to the association between the sodium-glucose cotransporter-2 (SGLT2) inhibitors drugs and diabetic ketoacidosis (DKA). More recently, there was an FDA announcement concerning a label change about the acute kidney injury side effect. What has received less attention, it seems, is the fact that these … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, Farxiga, Glyxambi, Invokamet, Invokana, Jardiance, Ketoacidosis, Pyelonephritis, Synjardy, Urosepsis, Xigduo

Invokana / Farxiga / Jardiance: Amputations; Lactic Acidosis; Ketoacidosis

July 19, 2016 By Law Offices of Thomas J. Lamb, P.A.

In July 2016 Boehringer Ingelheim Pharmaceuticals, Inc. received a Supplemental Approval letter from the FDA concerning a label change about fatal cases of ketoacidosis which have been reported concerning Jardiance, Synjardy, and Glyxambi. These relatively new diabetes medicines are part of the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Acute Kidney Injury, Amputations, Glyxambi, Invokamet, Invokana, Ketoacidosis, Lactic Acidosis, mesothelioma, Synjardy, Xigduo

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.